This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Takeda Pharmaceutical Company Limited, Scohia Pharma, Inc., Takeda Chemical Industries, Inc.. Active years: 2003-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyogo, JP (2006 - 2007)
- Ikeda, JP (2003 - 2009)
- Tokyo, JP (2015 - 2021)
Company Filing History:
10 out of 1,226 
1 out of 2 
1 out of 1,858 
Years Active: 2003-2021
Title: Seiji Miwatashi: Innovator in Aromatic Compound Research
Introduction
Seiji Miwatashi, based in Ikeda, Japan, is a pioneering inventor known for his significant contributions to the field of pharmaceuticals and metabolic disorder treatment. With a remarkable portfolio of 11 patents, Miwatashi's work focuses on innovative compounds that hold the potential to combat various health issues, including cancer and diabetes.
Latest Patents
Among Miwatashi's latest patents is an innovative aromatic compound that demonstrates GPR40 agonist activity and GLP-1 secretagogue action. This compound, represented by a specific formula, could play a pivotal role in the prophylaxis and treatment of serious health conditions such as cancer, obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, and sarcopenia. The efficacy of this compound may surpass existing treatments, marking a significant advancement in medical science.
Another groundbreaking patent involves substituted cyclic-acetic acid derivatives intended for the treatment of metabolic disorders. Similar to his previous work, this compound is formulated to exhibit GPR40 agonist activity and GLP-1 secretagogue action, reinforcing his focus on developing therapies that target multifaceted health challenges.
Career Highlights
Seiji Miwatashi has made substantial strides in his career while working with esteemed organizations such as Takeda Pharmaceutical Company Limited and Scohia Pharma, Inc. His affiliation with these companies has allowed him to apply his inventive skills in a collaborative and resource-rich environment, leveraging state-of-the-art research facilities and deep industry knowledge.
Collaborations
Throughout his career, Miwatashi has collaborated with renowned professionals, including Shigenori Ohkawa and Yuko Hitomi. These partnerships have fostered a dynamic exchange of ideas, enhancing the innovative outcomes of their collective research efforts.
Conclusion
Seiji Miwatashi's relentless pursuit of innovation has positioned him as a leader in the pharmaceutical field. With his latest patents focusing on novel aromatic compounds, he is set to contribute significantly to the treatment of critical health conditions. As he continues to work alongside talented colleagues and influential companies, the impact of his inventions is expected to resonate for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile